Question 1

What is ERAS stock price today?

Accepted Answer

Erasca, Inc. (ERAS) is currently trading at $18.16, up 1.35% today.

Question 2

What is ERAS market cap?

Accepted Answer

Erasca, Inc. has a market capitalization of $6 billion, making it one of the notable companies in the Healthcare sector.

Question 3

What is ERAS P/E ratio?

Accepted Answer

Erasca, Inc. has a P/E ratio of -19.53, which measures the stock price relative to its earnings per share.

Question 4

What is ERAS price target?

Accepted Answer

The average analyst price target for Erasca, Inc. is $28.00, which represents a 54.2% upside from the current price.

Question 5

What is ERAS 52-week high and low?

Accepted Answer

Erasca, Inc.'s 52-week high is $24.28 and 52-week low is $1.33. The current price of $18.16 is 73% of its 52-week range.

Question 6

What do analysts say about ERAS?

Accepted Answer

Analysts currently rate Erasca, Inc. as Strong Buy. Coverage is updated daily from major firms.

Question 7

Does ERAS pay a dividend?

Accepted Answer

Erasca, Inc. (ERAS) does not currently pay a dividend. The company reinvests profits back into growth and operations.

Question 8

What sector is ERAS in?

Accepted Answer

Erasca, Inc. (ERAS) operates in the Healthcare sector within the Biotechnology industry. You can explore other stocks in this sector on our Healthcare sector page.

Question 9

How has ERAS performed this year?

Accepted Answer

Erasca, Inc. (ERAS) has a year-to-date return of +381.7%. This significantly outperforms the broader market.

Question 10

Is ERAS overvalued or undervalued?

Accepted Answer

Erasca, Inc. has a forward P/E ratio of -38.8 compared to its trailing P/E of -19.5. A lower forward P/E suggests analysts expect earnings growth. Visit the ERAS stock page for detailed valuation analysis.

Erasca, Inc.

Price chart

Price performance

The thesis at a glance

Who's buying ERAS right now

Recent earnings results

8 analysts · 88% Buy

How ERAS stacks vs Biotechnology

Peers & themes